Cargando…
Dyrk1 inhibition improves Alzheimer's disease‐like pathology
There is an urgent need for the development of new therapeutic strategies for Alzheimer's disease (AD). The dual‐specificity tyrosine phosphorylation‐regulated kinase‐1A (Dyrk1a) is a protein kinase that phosphorylates the amyloid precursor protein (APP) and tau and thus represents a link betwe...
Autores principales: | Branca, Caterina, Shaw, Darren M., Belfiore, Ramona, Gokhale, Vijay, Shaw, Arthur Y., Foley, Christopher, Smith, Breland, Hulme, Christopher, Dunckley, Travis, Meechoovet, Bessie, Caccamo, Antonella, Oddo, Salvatore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595697/ https://www.ncbi.nlm.nih.gov/pubmed/28779511 http://dx.doi.org/10.1111/acel.12648 |
Ejemplares similares
-
β-Carboline Compounds, Including Harmine, Inhibit DYRK1A and Tau Phosphorylation at Multiple Alzheimer's Disease-Related Sites
por: Frost, Danielle, et al.
Publicado: (2011) -
DYRK1A antagonists rescue degeneration and behavioural deficits of in vivo models based on amyloid-β, Tau and DYRK1A neurotoxicity
por: Zhu, Bangfu, et al.
Publicado: (2022) -
The Omnipresence of DYRK1A in Human Diseases
por: Deboever, Estelle, et al.
Publicado: (2022) -
Temporal and regional progression of Alzheimer’s disease‐like pathology in 3xTg‐AD mice
por: Belfiore, Ramona, et al.
Publicado: (2018) -
Pim1 inhibition as a novel therapeutic strategy for Alzheimer’s disease
por: Velazquez, Ramon, et al.
Publicado: (2016)